Please use this identifier to cite or link to this item: https://biore.bio.bg.ac.rs/handle/123456789/843
DC FieldValueLanguage
dc.contributor.authorTrišović, Nemanjaen_US
dc.contributor.authorBožić, Bojanen_US
dc.contributor.authorObradović, Anaen_US
dc.contributor.authorStefanović, Olgicaen_US
dc.contributor.authorMarković, Snežanaen_US
dc.contributor.authorČomić, Ljiljanaen_US
dc.contributor.authorBožić, Biljanaen_US
dc.contributor.authorUšćumlić, Gordanaen_US
dc.date.accessioned2019-07-13T22:22:38Z-
dc.date.available2019-07-13T22:22:38Z-
dc.date.issued2011-12-13-
dc.identifier.issn0352-5139-
dc.identifier.urihttps://biore.bio.bg.ac.rs/handle/123456789/843-
dc.description.abstractA series of twelve 3-substituted-5,5-diphenylhydantoins was synthesized, including some whose anticonvulsant activities have already been reported in the literature. Their antiproliferative activities against HCT-116 human colon carcinoma cells were evaluated to determine structure-activity relationships. Almost all of the compounds exhibited statistically significant antiproliferative effects at a concentration of 100 μM, while the derivative bearing a benzyl group was active even at lower concentrations. Moreover, their in vitro antibacterial activities against Escherichia coli ATCC 25922, Staphylococcus aureus ATCC 25923 and clinical isolates of Escherichia coli, Proteus mirabilis, Pseudomonas aeruginosa, Enterococcus faecalis and Staphylococcus aureus were evaluated. Only the 3-isopropyl and 3-benzyl derivatives showed weak antibacterial activities against the Gram-positive bacterium E. faecalis and the Gram-negative bacteria E. coli ATCC 25922 and E. coli. Copyright 2011 (CC) SCS.en_US
dc.language.isoenen_US
dc.relation.ispartofJournal of the Serbian Chemical Societyen_US
dc.subjectAntimicrobial activityen_US
dc.subjectAntiproliferative activityen_US
dc.subjectPhenytoin derivativesen_US
dc.subjectStructure-activity relationshipen_US
dc.titleStructure-activity relationships of 3-substituted-5,5-diphenylhydantoins as potential antiproliferative and antimicrobial agentsen_US
dc.typeArticleen_US
dc.identifier.doi10.2298/JSC110314143T-
dc.identifier.scopus2-s2.0-84858685963-
dc.identifier.urlhttps://api.elsevier.com/content/abstract/scopus_id/84858685963-
dc.description.rankM23en_US
dc.description.impact0.912en_US
dc.description.startpage1597en_US
dc.description.endpage1606en_US
dc.description.volume76en_US
dc.description.issue12en_US
item.languageiso639-1en-
item.cerifentitytypePublications-
item.openairetypeArticle-
item.fulltextWith Fulltext-
item.grantfulltextrestricted-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.deptChair of General Physiology and Biophysics-
crisitem.author.deptChair of General Physiology and Biophysics-
crisitem.author.orcid0000-0001-9910-2741-
crisitem.author.orcid0000-0002-1238-1731-
Appears in Collections:Journal Article
Show simple item record

SCOPUSTM   
Citations

14
checked on Nov 20, 2024

Google ScholarTM

Check

Altmetric

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.